BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29171324)

  • 1. Obstructive and restrictive pulmonary dysfunction in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation.
    Stenehjem JS; Smeland KB; Murbraech K; Holte H; Kvaløy SO; Wethal T; Kiserud CE; Samersaw-Lund MB
    Acta Oncol; 2018 Jun; 57(6):773-781. PubMed ID: 29171324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiorespiratory fitness in long-term lymphoma survivors after high-dose chemotherapy with autologous stem cell transplantation.
    Stenehjem JS; Smeland KB; Murbraech K; Holte H; Kvaløy S; Thorsen L; Arbo I; Jones LW; Aakhus S; Lund MB; Kiserud CE
    Br J Cancer; 2016 Jul; 115(2):178-87. PubMed ID: 27351215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation.
    Kiserud CE; Fagerli UM; Smeland KB; Fluge Ø; Bersvendsen H; Kvaløy S; Holte H; Dahl AA
    Acta Oncol; 2016 May; 55(5):547-53. PubMed ID: 27123741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation.
    Hernæs KH; Smeland KB; Fagerli UM; Kiserud CE
    BMC Cancer; 2021 Feb; 21(1):143. PubMed ID: 33557789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation.
    Seland M; Smeland KB; Bjøro T; Falk RS; Fosså SD; Gjesdal CG; Godang K; Holte H; Svartberg J; Syversen U; Bollerslev J; Kiserud CE
    Acta Oncol; 2017 Apr; 56(4):590-598. PubMed ID: 28077016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart Failure and Asymptomatic Left Ventricular Systolic Dysfunction in Lymphoma Survivors Treated With Autologous Stem-Cell Transplantation: A National Cross-Sectional Study.
    Murbraech K; Smeland KB; Holte H; Loge JH; Lund MB; Wethal T; Holte E; Rösner A; Dalen H; Kvaløy S; Falk RS; Aakhus S; Kiserud CE
    J Clin Oncol; 2015 Aug; 33(24):2683-91. PubMed ID: 26169610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes.
    Bersvendsen HS; Haugnes HS; Fagerli UM; Fluge Ø; Holte H; Smeland KB; Wilsgaard T; Kiserud CE
    Acta Oncol; 2019 May; 58(5):690-699. PubMed ID: 30696346
    [No Abstract]   [Full Text] [Related]  

  • 8. Survivors' knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma.
    Simensen VC; Smeland KB; Kiserud CE; Dahl AA; Bersvendsen HS; Fluge Ø; Fagerli UM; Fosså A
    Acta Oncol; 2019 Sep; 58(9):1315-1322. PubMed ID: 31286808
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary function in long-term survivors of testicular cancer.
    Haugnes HS; Aass N; Fosså SD; Dahl O; Brydøy M; Aasebø U; Wilsgaard T; Bremnes RM
    J Clin Oncol; 2009 Jun; 27(17):2779-86. PubMed ID: 19414680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma.
    Smeland KB; Kiserud CE; Lauritzsen GF; Blystad AK; Fagerli UM; Falk RS; Fluge Ø; Fosså A; Kolstad A; Loge JH; Maisenhölder M; Østenstad B; Kvaløy S; Holte H
    Br J Haematol; 2016 May; 173(3):432-43. PubMed ID: 26914167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors for lung toxicity in pediatric cancer survivors].
    López Andreu JA; Compte Torrero L; Ferrís Tortajada J; Domenech Clar R; Pérez Tarazona S; Pellicer Porres C; Cortina Orts H; Roqués Serradilla JM
    An Esp Pediatr; 1999 Nov; 51(5):505-11. PubMed ID: 10652802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life.
    Smeland K; Holte H; Fagerli UM; Bersvendsen H; Hjermstad MJ; Loge JH; Murbrach K; Linnsund MD; Fluge O; Stenehjem JS; Lund MB; Kvaloy S; Kiserud CE
    Haematologica; 2022 Nov; 107(11):2698-2707. PubMed ID: 35484681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of life-threatening complications following autologous stem cell transplantation in patients with lymphoma.
    Kerhuel L; Amorim S; Azoulay E; Thiéblemont C; Canet E
    Leuk Lymphoma; 2015; 56(11):3090-5. PubMed ID: 25813206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary complications in survivors of childhood hematological malignancies: single-center experience.
    Tantawy AA; Elbarbary N; Ahmed A; Mohamed NA; Ezz-Elarab S
    Pediatr Hematol Oncol; 2011 Aug; 28(5):403-17. PubMed ID: 21728717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma.
    Gisselbrecht C; Lepage E; Molina T; Quesnel B; Fillet G; Lederlin P; Coiffier B; Tilly H; Gabarre J; Guilmin F; Hermine O; Reyes F;
    J Clin Oncol; 2002 May; 20(10):2472-9. PubMed ID: 12011124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary function impairment in children following hematopoietic stem cell transplantation.
    Wieringa J; van Kralingen KW; Sont JK; Bresters D
    Pediatr Blood Cancer; 2005 Sep; 45(3):318-23. PubMed ID: 15747333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
    Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
    J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study.
    Baech J; Husby S; Trab T; Kragholm K; Brown P; Gørløv JS; Jørgensen JM; Gudbrandsdottir S; Severinsen MT; Grønbaek K; Larsen TS; Wästerlid T; Eloranta S; Smeland KB; Jakobsen LH; El-Galaly TC
    Br J Haematol; 2024 Mar; 204(3):967-975. PubMed ID: 38155503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valvular Dysfunction in Lymphoma Survivors Treated With Autologous Stem Cell Transplantation: A National Cross-Sectional Study.
    Murbraech K; Wethal T; Smeland KB; Holte H; Loge JH; Holte E; Rösner A; Dalen H; Kiserud CE; Aakhus S
    JACC Cardiovasc Imaging; 2016 Mar; 9(3):230-9. PubMed ID: 26897666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
    Milgrom SA; Jauhari S; Plastaras JP; Nieto Y; Dabaja BS; Pinnix CC; Smith GL; Allen PK; Lukens JN; Maity A; Oki Y; Fanale MA; Nasta SD
    Cancer; 2017 Apr; 123(8):1363-1371. PubMed ID: 27984652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.